Emerging roles of deubiquitinating enzymes in human cancer
- 1 September 2007
- journal article
- review article
- Published by Springer Science and Business Media LLC in Acta Pharmacologica Sinica
- Vol. 28 (9), 1325-1330
- https://doi.org/10.1111/j.1745-7254.2007.00687.x
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Expression of protein gene product 9·5 (PGP9·5)/ubiquitin‐C‐terminal hydrolase 1 (UCHL‐1) in human myeloma cellsBritish Journal of Haematology, 2004
- Role of Rpn11 Metalloprotease in Deubiquitination and Degradation by the 26 S ProteasomeScience, 2002
- The UCH-L1 Gene Encodes Two Opposing Enzymatic Activities that Affect α-Synuclein Degradation and Parkinson's Disease SusceptibilityCell, 2002
- A cryptic protease couples deubiquitination and degradation by the proteasomeNature, 2002
- Ubiquitination and deubiquitination: Targeting of proteins for degradation by the proteasomeSeminars in Cell & Developmental Biology, 2000
- PGP9.5 As a Candidate Tumor Marker for Non-Small-Cell Lung CancerThe American Journal of Pathology, 1999
- Ubiquitin and the Biology of the CellPublished by Springer Science and Business Media LLC ,1998
- The Neuron-Specific Protein PGP 9.5 Is a Ubiquitin Carboxyl-Terminal HydrolaseScience, 1989
- Neural markers in carcinoma of the lungBritish Journal of Cancer, 1985
- PGP 9.5, a new marker for human neuroendocrine tumoursHistopathology, 1985